胸膜上皮瘤中的潜在生物标志物:胸膜瘤和胸膜癌
Rohan Maniar1, Patrick J Loehrer1
11Division of Hematology & Oncology, Indiana University School of Medicine, Indianapolis, IN.
Journal of the National Comprehensive Cancer Network : JNCCN
|March 13, 2026
概括
发现罕见胸膜上皮瘤 (TETs) 的可靠生物标志物至关重要. 多组学和人工智能提供了新的见解,但需要合作来推进精准医学和针对这些具有挑战性的癌症的向治疗.
科学领域:
- 在瘤学瘤学.
- 生物标志物发现发现
- 精准医学是一门精准的医学.
背景情况:
- 胸膜上皮瘤 (TETs),包括胸膜瘤和胸膜癌,是罕见且异质的恶性瘤.
- 它们的复杂性带来了重大的诊断和治疗挑战.
- 需要可靠的生物标志物来改善分类和治疗策略.
研究的目的:
- 为了突出诊断和治疗罕见的胸膜上皮瘤的挑战.
- 强调多原子方法和人工智能在TETs生物标志物发现方面的潜力.
- 强调需要共同努力,以加速临床转化和治疗开发.
主要方法:
- 审查当前关于胸膜上皮瘤的研究.
- 整合多原子数据和人工智能用于生物标志物识别.
- 对罕见病临床翻译方面的挑战进行分析.
主要成果:
- 多原子方法和人工智能正在为TET病原和脆弱性提供新的见解.
- 生物标志物的发现正在进步,但临床应用有限.
- 由于TETs的稀有性,需要共同的研究努力.
结论:
- 基于生物标志物的精密医学对于推进TET管理中的风险分层至关重要.
- 有针对性的治疗策略需要进一步开发和验证.
- 合作研究是克服罕见胸膜上皮瘤所带来的挑战的关键.
相关概念视频
02:17The Tumor Microenvironment
6.3K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.3K
01:27Tumor Immunotherapy
2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K